Clinical trials
Completed Constipation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
528 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 8 |
| 2004 | 7 |
| 2005 | 13 |
| 2006 | 17 |
| 2007 | 20 |
| 2008 | 23 |
| 2009 | 22 |
| 2010 | 29 |
| 2011 | 25 |
| 2012 | 30 |
| 2013 | 33 |
| 2014 | 24 |
| 2015 | 22 |
| 2016 | 25 |
| 2017 | 21 |
| 2018 | 31 |
| 2019 | 19 |
| 2020 | 23 |
| 2021 | 19 |
| 2022 | 17 |
| 2023 | 27 |
| 2024 | 20 |
| 2025 | 13 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 528 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Movetis | 17 |
| Braintree Laboratories | 15 |
| Bausch Health Americas, Inc. | 14 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 7 |
| Mayo Clinic | 7 |
| Augusta University | 6 |
| Riphah International University | 6 |
| Bayer | 5 |
| Forest Laboratories | 5 |
| Glycyx Therapeutics | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Constipation | 528 |
| Diarrhea | 41 |
| Irritable Bowel Syndrome | 36 |
| Abdominal Pain | 23 |
| Fecal Incontinence | 23 |
| Opioid-Induced Constipation | 18 |
| Pain | 17 |
| Parkinson Disease | 12 |
| Intestinal Diseases | 10 |
| Digestive System Diseases | 9 |
Trials
Showing 76 to 100 of 528. Each trial links to its page on Pharma Observatory.
428 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.